Cancer Genetics (CGIX) Lowers IPO Amount to 1.65M Shares
Tweet Send to a Friend
Cancer Genetics (Nasdaq: CGIX) filed an amended registration with the U.S. SEC for an Initial Public Offering of its Common Stock. The company plans to sell 1.65 million shares and sees an offering price of $10 to $12 per share. This compares with the company's previous filing, which called for the sale of 1.85 million shares and sees an offering price of $10 to $12 per share. Prior expectations from the company called for a range of $4 to $6 per share and volume of 5 million shares. The company plans to list on the NASDAQ exchange under the symbol "CGIX."
The offering is being made through Aegis Capital Corp and Feltl and Company.
Cancer Genetics is an early-stage diagnostics company focused on developing and commercializing proprietary genomic tests and services to improve and personalize the diagnosis, prognosis and response to treatment (theranosis) of cancer. The proprietary tests being developed target cancers that are difficult to prognose and predict treatment outcomes by using currently available mainstream techniques. These cancers include hematological, urogenital and HPV-associated cancers.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The offering is being made through Aegis Capital Corp and Feltl and Company.
Cancer Genetics is an early-stage diagnostics company focused on developing and commercializing proprietary genomic tests and services to improve and personalize the diagnosis, prognosis and response to treatment (theranosis) of cancer. The proprietary tests being developed target cancers that are difficult to prognose and predict treatment outcomes by using currently available mainstream techniques. These cancers include hematological, urogenital and HPV-associated cancers.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Cancer Genetics Announces First Quarter 2013 Financial Results and Significant Business and Portfolio Progress
- Dan Loeb Builds Massive Stake in Sony (SNE), Wants Entertainment Arm Split
- William Lyon Homes (WLH) IPO Opens 8% Higher
Create E-mail Alert Related Categories
IPOs
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
